Immunomedics Inc
IMMU
IMMU was delisted on the 22nd of October, 2020.
313 hedge funds and large institutions have $7.38B invested in Immunomedics Inc in 2020 Q2 according to their latest regulatory filings, with 117 funds opening new positions, 91 increasing their positions, 81 reducing their positions, and 22 closing their positions.
432% more first-time investments, than exits
New positions opened: 117 | Existing positions closed: 22
203% more capital invested
Capital invested by funds: $2.44B → $7.38B (+$4.94B)
175% more call options, than puts
Call options by funds: $181M | Put options by funds: $66M
129% more funds holding in top 10
Funds holding in top 10: 7 → 16 (+9)
42% more funds holding
Funds holding: 220 → 313 (+93)
12% more repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 81
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$215M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$102M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$96.7M |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$61.8M |
| 5 |
Goldman Sachs
New York
|
+$61.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$82.4M |
| 2 |
State Street
Boston,
Massachusetts
|
-$82M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$61.6M |
| 4 |
Jennison Associates
New York
|
-$56M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$54.2M |
IMMU Hedge Fund Activity: Q2 2020 in Review
313 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q2 2020, worth a combined $7.38B — up 203% from $2.44B a quarter earlier.
Buyers outnumbered sellers: 117 funds opened new IMMU positions and 22 closed out — a net gain of 95 holders — while 91 added to existing stakes and 81 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $215M. The largest seller was Victory Capital Management, cutting an estimated $82.4M.
- 313 institutional investors held Immunomedics Inc (IMMU) as of Q2 2020, up from 220 in Q1 2020.
- Funds reported $7.38B of Immunomedics Inc stock for Q2 2020, up 203% quarter-over-quarter.
- 117 funds opened new Immunomedics Inc positions in Q2 2020 and 22 closed out, a net change of +95 holders.
- The largest Immunomedics Inc buyer in Q2 2020 was Fidelity Investments, an estimated $215M added.
- The largest Immunomedics Inc seller in Q2 2020 was Victory Capital Management, an estimated $82.4M sold.
Based on aggregated 13F filings for Q2 2020.